Effect of ulinastatin on cytokine reaction during gastrectomy

Korean Journal of Anesthesiology

Volumn 58, Issue 4, 2010, Pages 334-337

  Park, Ji Hun ^a   Kwak, Sang Hyun ^a   Jeong, Cheol Won ^a   Bae, Hong Beom ^a   Kim, Seok Jai ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Gastrectomy; Inflammatory cytokine; Interleukin 6; Urinary trypsin inhibitor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; ULINASTATIN;

ADULT; ARTERIAL GAS; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG EFFECT; FEMALE; GASTRECTOMY; HUMAN; INFLAMMATION; MALE; SURGICAL STRESS;

EID: 77953431812     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2010.58.4.334     Document Type: Article

References (24)

1. Angele MK, Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 2002; 6: 298-305. (Pubitemid 34863695)
2. Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC Jr. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 1999; 178: 564-569
3. Biffl WL, Moore EE, Moore FA, Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996; 224: 647-664
4. Nakamura H, Abe S, Shibata Y, Sata M, Kato S, Saito H, et al. Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells. Int Arch Allergy Immunol 1997; 112: 157-162 (Pubitemid 27039180)
5. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 2001; 15: 101-105 (Pubitemid 33598169)
6. Pallua N, Low JF, von Heimburg D. Pathogenic role of interleukin-6 in the development of sepsis. Part II: significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model. Crit Care Med 2003; 31: 1495-1501
7. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18: 717-721
8. Cartmell T, Poole S, Turnbull AV, Rothwell NJ, Luheshi GN. Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol 2000; 526: 653-661 (Pubitemid 30654768)
9. Kodama T, Yukioka H, Kato T, Kato N, Hato F, Kitagawa S. Neutrophil elastase as a predicting factor for development of acute lung injury. Intern Med 2007; 46: 699-704. (Pubitemid 46902263)
10. Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 1998; 76: 91-94 (Pubitemid 28363861)
11. Inoue K, Takano H, Sato H, Yanagisawa R, Yoshikawa T. Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice. Immunopharmacol Immunotoxicol 2009; 31: 446-450
12. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891
13. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, et al. Molecular cloning of a human monocytederived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167: 1883-1893.
14. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 1990; 265: 21128-21133 (Pubitemid 120014130)
15. Sekido N, Mukaida N, Harada A, Nakanish I, Watanabe Y, Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993; 365: 654-657 (Pubitemid 23350537)
16. Kawamura T, Inada K, Okada H, Okada K, Wakusawa R. Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery. Can J Anaesth 1995; 42: 399-403.
17. Raijmakers PG, Groeneveld AB, Rauwerda JA, Schneider AJ, Teule GJ, Hack CE, et al. Transient increase in interleukin-8 and pulmonary microvascular permeability following aortic surgery. Am J Respir Crit Care Med 1995; 151: 698-705.
18. Hirose J, Ozawa T, Miura T, Isaji M, Nagao Y, Yamashiro K, et al. Human neutrophil elastase degrades inter-alpha-trypsin inhibitor to liberate urinary trypsin inhibitor related proteins. Biol Pharm Bull 1998; 21: 651-656 (Pubitemid 28374433)
19. Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Yoshino S, et al. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med 2005; 230: 281-287 (Pubitemid 40478253)
20. Yano T, Anraku S, Nakayama R, Ushijima K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology 2003; 98: 465-473 (Pubitemid 36592816)
21. Aibiki M, Cook JA. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit Care Med 1997; 25: 430-434 (Pubitemid 27152736)
22. Yoo JW, Ryu JK, Lee SH, Woo SM, Park JK, Yoon WJ, et al. Preven tive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas 2008; 37: 366-370
23. Taylor NM, Lacoumenta S, Hall GM. Fentanyl and the interleukin-6 response to surgery. Anaesthesia 1997; 52: 112-115
24. Hines RL, Marschall KE. Anesthesia and co-existing disease. 5th ed. Philadelphia, Churchill Livingstone. 1993, pp 276-278